Cargando…

β2‐adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma

BACKGROUND: Vascular endothelial growth factor (VEGF) was initially known as vascular permeability factor and identified as a driver of tumour angiogenesis. Recently, its role in supporting an immunosuppressive tumour microenvironment was demonstrated, and anti‐VEGF treatment combined with immune ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schuster, Cornelia, Akslen, Lars A., Straume, Oddbjørn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524038/ https://www.ncbi.nlm.nih.gov/pubmed/37551424 http://dx.doi.org/10.1002/cam4.6424

Ejemplares similares

Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy
por: Schuster, Cornelia, et al.
Publicado: (2018)

Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study
por: Schuster, Cornelia, et al.
Publicado: (2016)

Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension
por: Schuster, Cornelia, et al.
Publicado: (2012)

HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?
por: Seo, Mikyung Kelly, et al.
Publicado: (2020)

ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab
por: Forthun, Rakel Brendsdal, et al.
Publicado: (2019)

Tumour cell expression of interleukin 6 receptor α is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma
por: Pilskog, Martin, et al.
Publicado: (2018)

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
por: Ladstein, Rita G, et al.
Publicado: (2010)

Tumor necrosis is associated with increased alpha(v)beta(3 )integrin expression and poor prognosis in nodular cutaneous melanomas
por: Bachmann, Ingeborg M, et al.
Publicado: (2008)

Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma
por: Hugdahl, Emilia, et al.
Publicado: (2019)

Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer
por: Krüger, Kristi, et al.
Publicado: (2021)

Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma
por: Pilskog, Martin, et al.
Publicado: (2017)

Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma
por: Straume, O, et al.
Publicado: (2005)

Lymphatic vessel density and prognosis in cutaneous melanoma
por: Straume, O, et al.
Publicado: (2004)

Muscle Plasticity and β(2)-Adrenergic Receptors: Adaptive Responses of β(2)-Adrenergic Receptor Expression to Muscle Hypertrophy and Atrophy
por: Sato, Shogo, et al.
Publicado: (2011)

Differences in metastatic patterns in relation to time between primary surgery and first relapse from breast cancer suggest synchronized growth of dormant micrometastases
por: Dillekås, Hanna, et al.
Publicado: (2014)

Effect of β2-Adrenergic Receptor Polymorphism in Asthma Control of Patients Receiving Combination Treatment
por: Kim, Seung-Hyun, et al.
Publicado: (2009)

Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma
por: Hugdahl, Emilia, et al.
Publicado: (2018)

Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer
por: Franco, Thérèse H, et al.
Publicado: (2008)

Expression of β1 adrenergic receptor in vascular anomalies in children
por: Stănciulescu, Maria-Corina, et al.
Publicado: (2021)

Internalization Dissociates β(2)-Adrenergic Receptors
por: Lan, Tien-Hung, et al.
Publicado: (2011)

The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma
por: Mansfield, Aaron S., et al.
Publicado: (2013)

Gi-protein-coupled β (1)-adrenergic receptor: re-understanding the selectivity of β (1)-adrenergic receptor to G protein : Gi-protein-coupled β (1)-adrenergic receptor
por: Chen, Hao, et al.
Publicado: (2022)

Are 90% of deaths from cancer caused by metastases?
por: Dillekås, Hanna, et al.
Publicado: (2019)

Phosphodiesterase 4D disruption causes β2 adrenergic receptors to behave like β1 adrenergic receptors in vivo
por: Pearl, N, et al.
Publicado: (2006)

β(2)-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC
por: Lucido, Christopher T., et al.
Publicado: (2018)

Cardiac physiologic regulation of sub-type specific adrenergic receptors in transgenic mice overexpressing β(1)- and β(2)-adrenergic receptors
por: Kim, Ka Eul, et al.
Publicado: (2016)

Agonist-Directed Desensitization of the β(2)-Adrenergic Receptor
por: Goral, Vasiliy, et al.
Publicado: (2011)

Anticoagulant therapy for venous thromboembolism detected by Doppler ultrasound in patients with metastatic colorectal cancer receiving bevacizumab
por: Suenaga, Mitsukuni, et al.
Publicado: (2015)

Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy
por: Smeets, Dominiek, et al.
Publicado: (2018)

β-Adrenergic Receptor Signaling in Prostate Cancer
por: Braadland, Peder Rustøen, et al.
Publicado: (2015)

Optodynamic simulation of β-adrenergic receptor signalling
por: Siuda, Edward R., et al.
Publicado: (2015)

β-Adrenergic Receptor and Insulin Resistance in the Heart
por: Mangmool, Supachoke, et al.
Publicado: (2017)

Pharmacophore‐guided Virtual Screening to Identify New β(3)‐adrenergic Receptor Agonists
por: Ujiantari, Navista Sri Octa, et al.
Publicado: (2022)

Post-Mortem Immunohistochemical Evidence of β2-Adrenergic Receptor Expression in the Adrenal Gland
por: Ventura Spagnolo, Elvira, et al.
Publicado: (2019)

β2-Adrenergic receptor expression in subchondral bone of patients with varus knee osteoarthritis
por: Yang, Xiaochun, et al.
Publicado: (2022)

Characterization of β-adrenergic receptors in bovine intramuscular and subcutaneous adipose tissue: comparison of lubabegron fumarate with β-adrenergic receptor agonists and antagonists
por: Hwang, Jinhee H, et al.
Publicado: (2021)

Distant metastasis dynamics following subsequent surgeries after primary breast cancer removal
por: Demicheli, Romano, et al.
Publicado: (2019)

Bevacizumab in the therapy for refractory metastatic colorectal cancer
por: Mulcahy, Mary F
Publicado: (2008)

The effect of antecedent hypoglycaemia on β(2)-adrenergic sensitivity in healthy participants with the Arg16Gly polymorphism of the β(2)-adrenergic receptor
por: Schouwenberg, B. J. J. W., et al.
Publicado: (2011)

Mechanism of allosteric regulation of β(2)-adrenergic receptor by cholesterol
por: Manna, Moutusi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_69gbfai8nf1q1ujqhmdvg3ih8s